Consensus on acromegaly complications: an update.

IF 3.8 2区医学 Q2 ENDOCRINOLOGY & METABOLISM

Pituitary Pub Date : 2026-04-29 DOI:10.1007/s11102-026-01639-z

Andrea Giustina, Luigi di Filippo, Maria Fleseriu, Rosario Pivonello, Stephan Petersenn, John Wass, Susan L Samson, Alberto M Pereira, Raúl M Luque, Betina Biagetti, Maria Chiara Zatelli, Ken K Y Ho, Cesar L Boguszewski, Aart Jan van der Lely, Mark Gurnell, Nienke Biermasz, Katharina Schilbach, Diego Ferone, Monica R Gadelha, Adriana G Ioachimescu, Ezio Ghigo, Christian J Strasburger, Pinar Kadioglu, Pietro Maffei, Niki Karavitaki, Mónica Marazuela, Michael Buchfelder, Sabrina Chiloiro, Anton Luger, Yona Greenman, Elena Valassi, Ignacio Bernabeu, Stefano Frara, Philippe Chanson, Thierry Brue, John Ayuk, Felipe F Casanueva, Annamaria Colao, Pietro Mortini, Sebastian Neggers, Manel Puig-Domingo, Meliha Melin Uygur, Shlomo Melmed

{"title":"Consensus on acromegaly complications: an update.","authors":"Andrea Giustina, Luigi di Filippo, Maria Fleseriu, Rosario Pivonello, Stephan Petersenn, John Wass, Susan L Samson, Alberto M Pereira, Raúl M Luque, Betina Biagetti, Maria Chiara Zatelli, Ken K Y Ho, Cesar L Boguszewski, Aart Jan van der Lely, Mark Gurnell, Nienke Biermasz, Katharina Schilbach, Diego Ferone, Monica R Gadelha, Adriana G Ioachimescu, Ezio Ghigo, Christian J Strasburger, Pinar Kadioglu, Pietro Maffei, Niki Karavitaki, Mónica Marazuela, Michael Buchfelder, Sabrina Chiloiro, Anton Luger, Yona Greenman, Elena Valassi, Ignacio Bernabeu, Stefano Frara, Philippe Chanson, Thierry Brue, John Ayuk, Felipe F Casanueva, Annamaria Colao, Pietro Mortini, Sebastian Neggers, Manel Puig-Domingo, Meliha Melin Uygur, Shlomo Melmed","doi":"10.1007/s11102-026-01639-z","DOIUrl":null,"url":null,"abstract":"<p><p>The 16th Acromegaly Consensus Conference in September 2024 updated recommendations on diagnosis and treatment of acromegaly comorbidities. Since the 2020 acromegaly comorbidity management guideline was published, new evidence has emerged on novel and known comorbidities and new treatment approaches. Forty-three experts in the management of acromegaly reviewed the current literature and assessed changes in clinical practice standards and management. Current outcome goals were considered and updated, with a focus on the impact of current and emerging treatments of these comorbidities. Participants assessed factors that determine pharmacological choices, as well as use of specific agents in the management of the most relevant acromegaly comorbidities. We present consensus recommendations highlighting optimization of evidence-based acromegaly comorbidities management.</p>","PeriodicalId":20202,"journal":{"name":"Pituitary","volume":"29 3","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13124806/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pituitary","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11102-026-01639-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

The 16th Acromegaly Consensus Conference in September 2024 updated recommendations on diagnosis and treatment of acromegaly comorbidities. Since the 2020 acromegaly comorbidity management guideline was published, new evidence has emerged on novel and known comorbidities and new treatment approaches. Forty-three experts in the management of acromegaly reviewed the current literature and assessed changes in clinical practice standards and management. Current outcome goals were considered and updated, with a focus on the impact of current and emerging treatments of these comorbidities. Participants assessed factors that determine pharmacological choices, as well as use of specific agents in the management of the most relevant acromegaly comorbidities. We present consensus recommendations highlighting optimization of evidence-based acromegaly comorbidities management.

查看原文本刊更多论文

肢端肥大症并发症的共识：最新进展。

2024年9月举行的第16届肢端肥大症共识会议更新了肢端肥大症合并症的诊断和治疗建议。自2020年肢端肥大症合并症管理指南发布以来，出现了新的和已知的合并症和新的治疗方法的新证据。43位肢端肥大症管理方面的专家回顾了当前的文献并评估了临床实践标准和管理方面的变化。考虑并更新了当前的结果目标，重点关注这些合并症的当前和新出现的治疗方法的影响。参与者评估了决定药物选择的因素，以及在最相关的肢端肥大症合并症的管理中使用特定药物的因素。我们提出共识建议，强调循证肢端肥大症合并症管理的优化。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Pituitary 医学-内分泌学与代谢

CiteScore

7.10

自引率

7.90%

发文量

审稿时长

6 months

期刊介绍： Pituitary is an international publication devoted to basic and clinical aspects of the pituitary gland. It is designed to publish original, high quality research in both basic and pituitary function as well as clinical pituitary disease. The journal considers: Biology of Pituitary Tumors Mechanisms of Pituitary Hormone Secretion Regulation of Pituitary Function Prospective Clinical Studies of Pituitary Disease Critical Basic and Clinical Reviews Pituitary is directed at basic investigators, physiologists, clinical adult and pediatric endocrinologists, neurosurgeons and reproductive endocrinologists interested in the broad field of the pituitary and its disorders. The Editorial Board has been drawn from international experts in basic and clinical endocrinology. The journal offers a rapid turnaround time for review of manuscripts, and the high standard of the journal is maintained by a selective peer-review process which aims to publish only the highest quality manuscripts. Pituitary will foster the publication of creative scholarship as it pertains to the pituitary and will provide a forum for basic scientists and clinicians to publish their high quality pituitary-related work.